Literature DB >> 21516408

Establishment and culture of leukemia-lymphoma cell lines.

Hans G Drexler1.   

Abstract

The advent of continuous human leukemia-lymphoma cell lines as a rich resource of abundant, accessible, and manipulable living cells has contributed significantly to a better understanding of the pathophysiology of hematopoietic tumors. The first leukemia-lymphoma cell lines were established in 1963 and since then large numbers of new cell lines have been described. The major advantages of continuous leukemia-lymphoma cell lines are the unlimited supply and worldwide availability of identical cell material and the infinite viable storability in liquid nitrogen. These cell lines are characterized generally by monoclonal origin and differentiation arrest, sustained proliferation in vitro under preservation of most cellular features, and by specific genetic alterations. Here some of the more promising techniques for establishing new leukemia-lymphoma cell lines and the basic principles for culturing these cells are described. Several clinical and cell culture parameters might have some influence on the success rate, e.g., choice of culture medium and culture conditions, specimen site of the primary cells, and status of the patient at the time of sample collection.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21516408     DOI: 10.1007/978-1-61779-080-5_16

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  3 in total

1.  Inhibition of O-GlcNAcase Sensitizes Apoptosis and Reverses Bortezomib Resistance in Mantle Cell Lymphoma through Modification of Truncated Bid.

Authors:  Sudjit Luanpitpong; Nawin Chanthra; Montira Janan; Jirarat Poohadsuan; Parinya Samart; Yaowalak U-Pratya; Yon Rojanasakul; Surapol Issaragrisil
Journal:  Mol Cancer Ther       Date:  2017-11-22       Impact factor: 6.261

2.  A porcine lymphoma-derived cell line co-expressing IgM, IgG and IgA.

Authors:  Kikumi Ogihara; Yuko Naya; Junichi Kamie; Shin Hisamatsu; Michi Kodama; Yoshiharu Ishikawa; Koichi Kadota
Journal:  J Vet Med Sci       Date:  2022-04-11       Impact factor: 1.105

3.  Cytotoxicity of CD56-positive lymphocytes against autologous B-cell precursor acute lymphoblastic leukemia cells.

Authors:  F Fei; M Lim; A A George; J Kirzner; D Lee; R Seeger; J Groffen; H Abdel-Azim; N Heisterkamp
Journal:  Leukemia       Date:  2014-08-19       Impact factor: 11.528

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.